SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-007544
Filing Date
2004-03-12
Accepted
2004-03-11 18:20:21
Documents
12
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2130620z10-k.htm 10-K 621291
3 EX 3.4 a2130620zex-3_4.htm EX-3.4 74773
4 EX 10.3 a2130620zex-10_3.htm EX-10.3 79809
5 EX 10.4 a2130620zex-10_4.htm EX-10.4 70199
6 EX 10.6 a2130620zex-10_6.htm EX-10.6 53719
7 EX 10.10 a2130620zex-10_10.htm EX-10.10 51151
8 EX 10.21 a2130620zex-10_21.htm EX-10.21 5310
9 EX 23.1 a2130620zex-23_1.htm EX-23.1 5172
10 EX 31.1 a2130620zex-31_1.htm EX-31.1 5441
11 EX 31.2 a2130620zex-31_2.htm EX-31.2 5416
12 EX 32.1 a2130620zex-32_1.htm EX-32.1 3238
13 EX 32.2 a2130620zex-32_2.htm EX-32.2 3194
  Complete submission text file 0001047469-04-007544.txt   981524
Mailing Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301
Business Address 4840 PEARL EAST CIRCLE SUITE 300W BOULDER CO 80301 3035303891
NAPRO BIOTHERAPEUTICS INC (Filer) CIK: 0000891504 (see all company filings)

IRS No.: 841187753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24320 | Film No.: 04663863
SIC: 2833 Medicinal Chemicals & Botanical Products